Finance

Beta
Lists
COLO-B:CPH
Coloplast A/S
DKK 386.70
+0.78%
(+3.00) 1D
Jun 9, 5:00:00 PM GMT+2  ·   DKK
All symbols
SymbolPriceChange% Change
Generating top insights for COLO-B...
Open
DKK 382.00
High
DKK 389.60
Low
DKK 381.50
Mkt. cap
80.65B
Avg. vol.
409.06K
Volume
345.54K
52-wk high
DKK 646.60
52-wk low
DKK 376.00
Shares outstanding
210.20M
No. of employees
17K
Open
DKK 382.00
High
DKK 389.60
Low
DKK 381.50
Mkt. cap
80.65B
Avg. vol.
409.06K
Volume
345.54K
52-wk high
DKK 646.60
52-wk low
DKK 376.00
Shares outstanding
210.20M
No. of employees
17K
Analyst outlook
Analyst Ratings
Based on 4 analysts giving stock ratings to COLO-B in the past 3 months
Hold
Buy
2
Hold
1
Sell
1
12 month forecast
Based on 4 Wall Street analysts offering 12 month price targets for COLO-B in the last 3 months.
Highest
Current CHF 386.70
CHF 65.25 (-83.13%)
Average
CHF 59.92 (-84.50%)
Lowest
CHF 53.55 (-86.15%)
News stories
From sources across the web
Profile
Coloplast A/S is a Danish multinational company that develops, manufactures and markets medical devices and services related to ostomy, urology, continence, and wound care. Wikipedia
About Coloplast A/S
CEO-
Employees17.1K
Founded1957
HeadquartersHumlebaek, Capital Region of Denmark, Denmark
SectorMedical device
Previous reportsAll values in DKK
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in DKK
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
6.96B
6.96B
7.04B
7.08B
Cost of goods sold
2.25B
2.20B
2.31B
2.37B
Cost of revenue
2.25B
2.20B
2.31B
2.37B
Research and development expenses
239.00M
249.00M
247.00M
254.00M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
2.58B
2.62B
2.64B
2.67B
Operating expense
2.79B
2.79B
2.88B
2.90B
Total operating expenses
5.04B
4.99B
5.19B
5.26B
Operating income
1.92B
1.97B
1.85B
1.82B
Other non operating income
-75.00M
-6.00M
42.00M
-188.00M
EBT including unusual items
1.34B
1.56B
1.79B
-1.24B
EBT excluding unusual items
1.42B
1.81B
1.83B
1.78B
Income tax expense
537.00M
680.00M
394.00M
-273.00M
Effective tax rate
40.01%
43.73%
22.00%
21.95%
Other operating expenses
-27.00M
-80.00M
-6.00M
-23.00M
Net income
805.00M
875.00M
1.40B
-971.00M
Net profit margin
11.57%
12.57%
19.84%
-13.71%
Earnings per share
4.93
4.67
-
6.16
Interest and investment income
-
22.00M
32.00M
149.00M
Interest expense
-415.00M
-152.00M
-164.00M
-
Net interest expenses
-415.00M
-130.00M
-132.00M
149.00M
Depreciation and amortization charges
-
-
-
-
EBITDA
2.26B
2.20B
2.20B
2.17B
Gain or loss from assets sale
46.00M
2.00M
-
1.00M
AI content may include mistakes. Learn more

Research

AI content may include mistakes. Learn more